We recently identified a single-nucleotide polymorphism within HEPH gene, leading to a missense variation of this multicopper ferroxidase, which confers protection against asbestos-dependent malignant pleural mesothelioma and lung carcinoma in exposed subjects (24, 25). The gene discussed is HEPH; the disease is lung carcinoma.